Bacteriophage Therapy in Patients With Urinary Tract Infections

  • End date
    Sep 12, 2023
  • participants needed
  • sponsor
    Adaptive Phage Therapeutics, Inc.
Updated on 12 December 2021


This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections.


This study will evaluate the safety and efficacy of bacteriophage therapy in patients with urinary tract infection (UTI). Patients to be enrolled will have urinary tract infections due to E. coli and K. pneumoniae. This will include asymptomatic patients with neurogenic bladder and symptomatic patients with complicated urinary tract infections who are at risk of UTI recurrence. Patients will be followed for bacterial clearance or recurrence of urinary tract infection.

Condition Urinary Tract Infection Bacterial
Treatment Bacteriophage Therapy, Bacteriophage Therapy
Clinical Study IdentifierNCT04287478
SponsorAdaptive Phage Therapeutics, Inc.
Last Modified on12 December 2021


Yes No Not Sure

Inclusion Criteria

Males or females ≥18 years of age
Female patients of childbearing potential
Male patients must agree not to donate sperm up for one month

Exclusion Criteria

Stage 4 or greater chronic kidney disease (CKD)
Abnormal liver function tests >3×upper limit of normal (ULN)
Other conditions which could confound study results
Body mass index of > 40 or weight less than 50 kg
Known allergy to phage products
Pregnant and/or breastfeeding
Need for antiviral medication
History of severe autonomic dysreflexia
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note